Effect of erythromycin lactobionate on pharmacokinetics of puerarin in rats

崔升淼,赵春顺,毛晶晶,何仲贵,陈大为
DOI: https://doi.org/10.3969/j.issn.1006-2858.2004.06.004
2004-01-01
Abstract:Objective To investigate the effect of erythromycin lactobionate on the pharmacokinetics of puerain in rats.Methods Puerarin with or without erythromycin lactobionate was administered intravenously to rats,respectively.The concentration of puerarin in serum was determined by HPLC,and the pharmacokinetic parameters were obtained by the pharmacokinetic software named 3P97.Results The pharmacokinetics of puerarin conformed to a two-compartment open model.No significant difference was found between the control and (0.25 g·L~(-1)),(2.50 g·L~(-1)) erythromycin lactobionate combined groups (P0.05),and there was significant difference between the control and 12.50 g·L~(-1) erythromycin lactobionate combined group (P0.01).When the dose of erythromycin lactobionate was below (2.5 g·L~(-1)),it had no effect on the pharmacokinetics of puerarin.But puerarin elimination was inhibited by erythromycin lactobionate when the dose was more than (12.50 g·L~(-1)).Conclusions It is necessary to change the therapeutic dose of puerarin when the drug is coadministered with erythromycin lactobionate.
What problem does this paper attempt to address?